Edmiston Elizabeth, Ashwood Paul, Van de Water Judy
Division of Rheumatology/Allergy and Clinical Immunology, University of California, Davis, Davis, California; The M.I.N.D. Institute, University of California, Davis, Davis, California.
The M.I.N.D. Institute, University of California, Davis, Davis, California; NIEHS Center for Children's Environmental Health, University of California, Davis, Davis, California; Department of Medical Microbiology and Immunology, University of California, Davis, Davis, California.
Biol Psychiatry. 2017 Mar 1;81(5):383-390. doi: 10.1016/j.biopsych.2016.08.031. Epub 2016 Sep 1.
Auism spectrum disorder (ASD) now affects one in 68 births in the United States and is the fastest growing neurodevelopmental disability worldwide. Alarmingly, for the majority of cases, the causes of ASD are largely unknown, but it is becoming increasingly accepted that ASD is no longer defined simply as a behavioral disorder, but rather as a highly complex and heterogeneous biological disorder. Although research has focused on the identification of genetic abnormalities, emerging studies increasingly suggest that immune dysfunction is a viable risk factor contributing to the neurodevelopmental deficits observed in ASD. This review summarizes the investigations implicating autoimmunity and autoantibodies in ASD.
自闭症谱系障碍(ASD)目前在美国每68例新生儿中就有1例受影响,并且是全球增长最快的神经发育障碍。令人担忧的是,对于大多数病例,ASD的病因在很大程度上尚不清楚,但越来越多的人接受这样的观点,即ASD不再仅仅被定义为一种行为障碍,而是一种高度复杂且异质性的生物障碍。尽管研究主要集中在识别基因异常,但越来越多的新研究表明,免疫功能障碍是导致ASD中观察到的神经发育缺陷的一个可行风险因素。本综述总结了涉及自身免疫和自身抗体与ASD关系的研究。